Apellis Pharmaceuticals Overview
Apellis Pharmaceuticals Target Price
Analysts' 12-month price predictions for APLS.
Get informed when a big investor buys or sells
+ FollowShare Price
$41.03
Average Target Price
$41.00
0.1% downside
0.1% downside1 analysts in the last 4 months
High: $41 | Low: $41
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-17 | Wells Fargo | $41 | 0.1% downside |  |
| 2026-01-27 | Barclays | $24 | 41.5% downside | |
| 2026-01-20 | Wells Fargo | $26 | 36.6% downside | |
| 2026-01-13 | Cantor Fitzgerald | $35 | 14.7% downside | |
| 2026-01-12 | Goldman Sachs | $19 | 53.7% downside | |
| 2025-12-19 | Stifel Nicolaus | $48 |  17% upside | |
| 2025-11-03 | Mizuho SecuritiesGraig Suvannavejh | $19 | 53.7% downside | |
| 2025-10-31 | Robert W. Baird | $52 | 26.7% upside | |
| 2025-10-31 | H.C. Wainwright | $45 | 9.7% upside | |
| 2025-10-29 | Mizuho Securities | $24 | 41.5% downside | |
| 2025-10-15 | Wells Fargo | $32 | 22% downside | |
| 2025-09-26 | Goldman Sachs | $18 | 56.1% downside | |
| 2025-07-30 | Scotiabank | $22 | 46.4% downside | |
| 2024-11-06 | H.C. WainwrightDouglas Tsao | $57 | 38.9% upside | |
| 2024-09-23 | Robert W. BairdColleen Kusy | $92 | 124.2% upside | |
| 2024-09-20 | Stifel NicolausAnnabel Samimy | $84 | 104.7% upside | |
| 2024-09-20 | Mizuho SecuritiesGraig Suvannavejh | $39 | 4.9% downside | |
| 2024-09-16 | Mizuho SecuritiesGraig Suvannavejh | $42 | 2.4% upside | |
| 2024-08-09 | Robert W. BairdColleen Kusy | $96 | 134% upside | |
| 2024-08-08 | JefferiesAkash Tewari | $82 | 99.9% upside | |
| 2024-08-02 | H.C. WainwrightDouglas Tsao | $83 | 102.3% upside | |
| 2024-07-26 | Robert W. BairdColleen Kusy | $86 | 109.6% upside | |
| 2024-07-01 | Mizuho SecuritiesGraig Suvannavejh | $49 | 19.4% upside | |
| 2024-05-23 | Wells FargoDerek Archila | $48 | 17% upside | |
| 2024-02-05 | JefferiesAkash Tewari | $80 | 95% upside | |
| 2023-01-02 | Wells FargoDerek Archila | $58 | 41.4% upside | |
| 2022-11-15 | J.P. Morgan | $79 | 92.5% upside | |
| 2022-09-12 | Wedbush | $67 | 63.3% upside | |
| 2022-09-08 | Stifel Nicolaus | $65 | 58.4% upside | |
| 2022-08-18 | Oppenheimer | $78 | 90.1% upside | |
| 2022-08-09 | Raymond James | $113 | 175.4% upside | |
| 2022-08-09 | Credit Suisse | $52 | 26.7% upside | |
| 2022-08-09 | Goldman Sachs | $102 | 148.6% upside | |
| 2022-07-20 | Citigroup | $86 | 109.6% upside | |
| 2022-06-23 | Stifel NicolausAnnabel Samimy | $60 | 46.2% upside | |
| 2022-05-24 | Goldman Sachs | $84 | 104.7% upside | |
| 2022-05-05 | Credit Suisse | $44 | 7.2% upside | |
| 2022-05-05 | Raymond James | $102 | 148.6% upside | |
| 2021-11-09 | WedbushLaura Chico | $28 | 31.8% downside | |
| 2021-11-09 | BMO CapitalMatthew Luchini | $69 | 68.2% upside | |
| 2021-10-01 | Cantor FitzgeraldAlethia Young | $74 | 80.4% upside | |
| 2021-10-01 | JefferiesChris Howerton | $74 | 80.4% upside | |
| 2021-09-10 | Credit SuisseTiago Fauth | $38 | 7.4% downside | |
| 2021-07-01 | Cowen & Co.Phil Nadeau | $70 | 70.6% upside | |